Antioxidant activity of beta-blockers: an effect mediated by scavenging reactive oxygen and nitrogen species?

Bioorganic & Medicinal Chemistry
Ana GomesEduarda Fernandes

Abstract

The therapeutic effects of beta-blockers are normally explained by their capacity to block the beta-adrenoceptors, however, some of the beneficial cardiovascular effects shown by this group of compounds have already been associated with the antioxidant properties that some of them seem to possess. The beta-blockers atenolol, labetalol, metoprolol, pindolol, propranolol, sotalol, timolol, and carvedilol were tested for their putative scavenging activity for ROS (O(2)(-), H(2)O(2), HO(.), HOCl, and ROO(.)) and RNS ((.)NO and ONOO(-)). Some of the studied compounds are effective ROS and/or RNS scavengers, these effects being possibly useful in preventing oxidative damage verified in hypertension as well as in other cardiovascular diseases that frequently emerge in association with oxidative stress.

References

Oct 1, 1990·Journal of Molecular and Cellular Cardiology·W B WeglickiM G Simìc
Oct 1, 1989·Circulation Research·I T MakW B Weglicki
Jan 1, 1985·Molecular Aspects of Medicine·B Halliwell, J M Gutteridge
Jun 1, 1995·Proceedings of the Society for Experimental Biology and Medicine·H Jaeschke
Nov 17, 1994·Annals of the New York Academy of Sciences·T L YueG Z Feuerstein
Jan 1, 1993·Free Radical Research Communications·R E Huie, S Padmaja
Jun 15, 1995·Analytical Chemistry·P Kostka
Jun 1, 1996·Journal of Chemical Neuroanatomy·V L Dawson, T M Dawson
Feb 1, 1997·General Pharmacology·O I Aruoma
Feb 1, 1997·Analytical Biochemistry·Y Xia, J L Zweier
Apr 4, 1998·Journal of Molecular and Cellular Cardiology·N KhaperP K Singal
Mar 24, 1998·Journal of Bioluminescence and Chemiluminescence·M M OosthuizenR D Levy
Aug 4, 1998·General Pharmacology·M P MurphyS W Martin
Sep 19, 1998·Free Radical Biology & Medicine·G L Squadrito, W A Pryor
Jan 30, 1999·Free Radical Research·B Tadolini, F Franconi
Mar 12, 1999·Journal of Molecular and Cellular Cardiology·S PersadN S Dhalla
Apr 8, 1999·Pharmacology & Toxicology·T MiuraY Fujimoto
Nov 11, 1999·Cell Death and Differentiation·P NicoteraG Melino
Jan 21, 2000·Free Radical Biology & Medicine·S B DigernessV Darley-Usmar
Feb 5, 2000·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·S K WattanapitayakulJ A Bauer
Feb 24, 2000·The Journal of Pathology·D L Carden, D N Granger
Apr 20, 2000·Redox Report : Communications in Free Radical Research·M M Oosthuizen, D Greyling
Nov 14, 2000·Circulation Research·H Cai, D G Harrison
Dec 19, 2000·Biochemical and Biophysical Research Communications·U KetsawatsakulB Halliwell
Dec 29, 2000·Current Opinion in Cardiology·A L CatapanoE Tragni
Jul 14, 2001·Redox Report : Communications in Free Radical Research·M M Oosthuizen, D Greyling
Oct 17, 2001·Journal of Cardiovascular Pharmacology·Z MartonK Toth
Feb 20, 2002·Journal of Molecular and Cellular Cardiology·Benjamin F DickensTong I Mak
Jun 19, 2002·Circulation·Kazufumi NakamuraTohru Ohe
Jun 22, 2002·Annals of the New York Academy of Sciences·M WhitemanB Halliwell
Oct 29, 2003·Hypertension·Yoshihiro Taniyama, Kathy K Griendling
Nov 11, 2003·The Journal of Nutrition·Stephanie D Wollin, Peter J H Jones
Dec 9, 2003·Amino Acids·B Alvarez, R Radi
Jan 22, 2004·Clinical Science·Carlene A HamiltonAnna F Dominiczak
Apr 20, 2004·Current Opinion in Nephrology and Hypertension·Nosratola D Vaziri
Apr 24, 2004·American Journal of Physiology. Heart and Circulatory Physiology·Keisuke KawaiChang-Seng Liang
Sep 1, 2004·Histochemistry and Cell Biology·R M Touyz, E L Schiffrin

❮ Previous
Next ❯

Citations

May 26, 2010·Analytical and Bioanalytical Chemistry·Giangiacomo Beretta, Roberto Maffei Facino
Jun 22, 2010·Analytical and Bioanalytical Chemistry·Joana P N RibeiroJosé L F C Lima
Oct 12, 2012·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Anastasia G PtinopoulouAnastasios N Lasaridis
Jan 12, 2013·PloS One·Rogerio Faustino RibeiroIvanita Stefanon
Oct 16, 2012·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Carol Chen-ScarabelliTiziano M Scarabelli
Feb 21, 2013·The Korean Journal of Thoracic and Cardiovascular Surgery·Ji Hoon KimSung Jin Kim
Feb 25, 2014·Life Sciences·Thatiana L Assis de BritoBruna Romana-Souza
Jul 30, 2014·Journal of Bioenergetics and Biomembranes·Figen Amber CicekBelma Turan
Jan 19, 2011·Journal of Proteomics·Angelo D'AlessandroLello Zolla
Jul 20, 2012·Environmental Toxicology and Pharmacology·Tae-Kil EomSe-Kwon Kim
Apr 11, 2012·International Journal of Vascular Medicine·Michiaki MiyamotoNobuyuki Taniguchi
Jul 1, 2008·Journal of the American Society of Hypertension : JASH·Melvin R Hayden, James R Sowers
May 1, 2007·Journal of the American Society of Hypertension : JASH·Rhian M TouyzErnesto L Schiffrin
Aug 19, 2007·Basic & Clinical Pharmacology & Toxicology·Marco Leal-GarcíaHéctor Sumano
Mar 1, 2015·The Journal of Membrane Biology·Mario SuwalskyNathan Dukes
Jul 15, 2011·Food Chemistry·Renan Campos ChistéNeura Bragagnolo
Dec 30, 2014·Antioxidants & Redox Signaling·Nadezda Apostolova, Victor M Victor
Oct 11, 2017·Antioxidants & Redox Signaling·Patrizia FerroniFiorella Guadagni
Jul 27, 2007·Basic & Clinical Pharmacology & Toxicology·Dragana A KastratovićAleksandra L Nikolić-Kokić
Sep 16, 2014·International Journal of Cancer. Journal International Du Cancer·Walter Lemmo
Apr 3, 2010·Pharmacological Reports : PR·Tadeusz Librowski, Andrzej Moniczewski
Aug 5, 2020·Clinical and Experimental Pharmacology & Physiology·Ajith KakaraparthiLingesh Allakonda
Jan 25, 2011·Clinical Cardiology·Kevin S HeffernanJeffrey T Kuvin
Feb 7, 2019·The Pharmacogenomics Journal·Santiago CuevasPedro A Jose
Dec 6, 2017·BioMed Research International·Adriana E BulboacăAngelo C Bulboacă
Nov 18, 2020·Drug and Chemical Toxicology·Abdolhamid EsmaeeliMohammad Seyedabadi
Apr 1, 2008·Analytica Chimica Acta·Luís M MagalhãesJosé L F C Lima

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Cardiovascular Homeostasis

Cardiovascular regulation and homeostasis is important in maintaining health and dysfunction may lead to cardiovascular diseases. Nitric oxide and vascular endothelium are one of many molecules involved in the homeostatic mechanism. Here is the latest research on cardiovascular homeostasis.